Benefit of consolidative radiation therapy in patients with diffuse large B-cell lymphoma treated with R-CHOP chemotherapy.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Journal of Clinical Oncology

• Publication date

  2010-09-20

• Fields of study

  Medicine

• Identifiers
  DOI 10.1200/JCO.2009.27.3441PMID 20713859
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Outcomes and effect of radiotherapy in patients with stage I or II diffuse large B-cell lymphoma: a surveillance, epidemiology, and end results analysis.

  2008cited by this paper
• The majority of transformed lymphomas have high standardized uptake values (SUVs) on positron emission tomography (PET) scanning similar to diffuse large B-cell lymphoma (DLBCL).

  2008cited by this paper
• Role of radiation therapy in localized aggressive lymphoma.

  2007cited by this paper
• CHOP alone compared with CHOP plus radiotherapy for localized aggressive lymphoma in elderly patients: a study by the Groupe d'Etude des Lymphomes de l'Adulte.

  2007influential reference
• Rituximab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma.

  2006cited by this paper
• CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group.

  2006cited by this paper
• Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: a study by the Groupe d'Etude des Lymphomes de l'Adulte.

  2005cited by this paper
• Residual disease after chemotherapy in aggressive malignant lymphoma

  2005cited by this paper
• ACVBP versus CHOP plus radiotherapy for localized aggressive lymphoma.

  2005influential reference
• Chemotherapy with or without radiotherapy in limited-stage diffuse aggressive non-Hodgkin's lymphoma: Eastern Cooperative Oncology Group study 1484.

  2004influential reference
• CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.Coiffier B,et al.N Engl J Med 2002;346(4):235-42--CHOP+リツキシマブ併用療法は、CHOP療法を上回る治療法であり、DLBCLの治療動向に大きなimpactを与えた

  2004cited by this paper
• Current trends in large cell lymphoma

  2003cited by this paper
• CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.

  2002cited by this paper
• CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell Lymphoma

  2002cited by this paper
• Dose-response analysis for radiotherapy delivered to patients with intermediate-grade and large-cell immunoblastic lymphomas that have completely responded to CHOP-based induction chemotherapy.

  2001cited by this paper
• Radiation therapy after a partial response to CHOP chemotherapy for aggressive lymphomas.

  2001cited by this paper
• Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

  2000cited by this paper
• Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate- and high-grade non-Hodgkin's lymphoma.

  1998cited by this paper
• Report of the Committee on Hodgkin's Disease Staging Classification.

  1971cited by this paper

• Metabolic Bulk Volume is an independent prognostic factor and facilitates identifying high risk cases for DLBCL patients treated with the R-CHOP.

  2026cites this paper
• The Role of Radiotherapy After Full Course of Chemotherapy in the Treatment of Diffuse Large B‐Cell Lymphoma: A Systematic Review and Meta‐Analysis

  2025cites this paper
• Advanced Stage Hodgkin and Diffuse Large B-Cell Lymphomas: Is There Still a Role for Consolidation Radiotherapy in the PET Era?

  2025cites this paper
• Germinal center B-cell diffuse large B-cell lymphoma presenting as a chin mass: a case report

  2025cites this paper
• Therapeutic approach to patients with early stage diffuse large B cell lymphoma: retrospective, multicenter, real-life study of the ‘RTL’ (regional Tuscan lymphoma network)

  2025cites this paper
• SOHO State of the Art Updates and Next Questions | Does Limited Stage Diffuse Large B-cell Lymphoma Matter?

  2025cites this paper
• Mathematical models of iron metabolism: structure and functions

  2025cites this paper
• Atypical CNS relapse in early-stage double-hit DLBCL: clinical implications for surveillance and prophylaxis

  2025cites this paper
• A Case of Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type in the Metatarsal Bone.

  2025cites this paper
• Association of overall survival benefit of radiotherapy with progression-free survival after chemotherapy for diffuse large B-cell lymphoma: A systematic review and meta-analysis

  2024cites this paper
• Influence of Organ‐Specific Extranodal Involvement on Survival Outcomes in Stage IV Diffuse Large B‐Cell Lymphoma

  2024cites this paper
• Clinical Outcomes in Patients With DLBCL Treated With R-CHOP According to Radiotherapy and Interim PET Response.

  2024cites this paper
• Benefit of consolidative radiation in patients with extranodal limited-stage diffuse large B-cell lymphoma: a multicenter retrospective study in China

  2024cites this paper
• Using Deauville Scoring to Guide Consolidative Radiotherapy in Diffuse Large B-Cell Lymphoma

  2024cites this paper
• Plasmablastic Lymphoma. A State-of-the-Art Review: Part 2-Focus on Therapy

  2024cites this paper
• Outcomes and toxicities in patients with diffuse-large B cell lymphoma involving the gastrointestinal tract and digestive organs

  2024cites this paper
• Long-Term Results of IFRT vs. ISRT in Infradiaphragmal Fields in Aggressive Non-Hodgkins’s Lymphoma Patients—A Single Centre Experience

  2024cites this paper
• Does Limited-Stage Diffuse Large B-Cell Lymphoma (LS-DLBCL) Matter?

  2024cites this paper
• Hypofractionated radiotherapy for refractory or relapsed aggressive B-cell lymphoma in the rituximab era

  2024cites this paper
• Definition of bulky disease in early stage diffuse large B-cell lymphoma in computed tomography on coronal and transverse planes

  2023cites this paper
• Radiotherapy dose de-escalation in patients with high grade non-Hodgkin lymphoma in a real-world clinical practice

  2023cites this paper
• MYC overexpression but not MYC/BCL2 double expression predicts survival in bulky mass diffuse large B‐cell lymphoma patients

  2023cites this paper
• Survival Outcomes of Limited-Stage Diffuse Large B-Cell Lymphoma Treated With Radiation Therapy.

  2023cites this paper
• Consolidative radiotherapy for residual fluorodeoxyglucose activity on day +30 post CAR T-cell therapy in non-Hodgkin lymphoma

  2023cites this paper
• Radiation and Dose-densification of R-CHOP in Aggressive B-cell Lymphoma With Intermediate Prognosis: The UNFOLDER Study

  2023cites this paper
• Efficacy and toxicity of infradiaphragmal radiotherapy fields in lymphoma patients: a single-centre experience

  2023cites this paper
• Consolidative Radiotherapy after Complete Remission following R-CHOP Immunochemotherapy in Stage III–IV Diffuse Large B-Cell Lymphoma Patients: A Systematic Review and Meta-Analysis

  2023cites this paper
• Decreased lymphoma-related deaths and improved long-term relative survival with radiotherapy for early-stage diffuse large B-cell lymphoma in the rituximab era.

  2023cites this paper
• Patients and Families’ Participation in Multidisciplinary Tumor Conferences Improves Patient and Family-Focused Cancer Care: Lessons Learned From a Debate on the Role of Radiation Therapy in Primary Mediastinal Non-Hodgkin Lymphoma

  2023influential citation
• Lymphomas and Total Body Irradiation

  2022cites this paper
• Balancing the Therapeutic Ratio in DLBCL Requires Appropriate, Individualized Patient Selection Rather Than Broad Elimination of Radiation Therapy.

  2022cites this paper
• Diffuse Large B-Cell Lymphoma of the Frontal Sinus: A Case Report

  2022cites this paper
• Pretreatment frailty is an independent prognostic factor among elderly patients with B‐cell lymphoma undergoing immunochemotherapy: A prospective observational cohort study in Taiwan

  2022cites this paper
• Evolution of therapy for limited stage diffuse large B-cell lymphoma

  2022cites this paper
• Ideal dose intensity of R-CHOP in diffuse large B-cell lymphoma

  2022cites this paper
• Positron Emission Tomography Molecular Imaging for Phenotyping and Management of Lymphoma

  2022cites this paper
• Treatment Modalities and Survival Outcomes for Sinonasal Diffuse Large B‐Cell Lymphoma

  2021cites this paper
• Reduced radiotherapy clinical benefit for primary Waldeyer's ring diffuse large B‐cell lymphoma in the rituximab era

  2021cites this paper
• PET response-guided radiotherapy for advanced DLBCL?

  2021cites this paper
• Characteristics of Non-Hodgkin's Lymphoma Head Of The Neck In Chemotherapy I At General Hospital Dr. Soetomo Surabaya

  2021influential citation
• PET-guided treatment for personalised therapy of Hodgkin lymphoma and aggressive non-Hodgkin lymphoma.

  2021cites this paper
• Improved Progression-Free Survival for Bulky and Non-Bulky Advanced Stage Diffuse Large B-Cell Lymphoma With Consolidative Radiation Therapy: A Bi-Institutional Analysis

  2021cites this paper
• Limited-stage Diffuse Large B-cell Lymphoma.

  2021cites this paper
• Non Hodgkin lymphoma in Lebanon: a retrospective epidemiological study between 1984 and 2019

  2021cites this paper
• PET CT in Non-Hodgkin Lymphoma

  2021cites this paper
• PET imaging of lymphomas

  2021cites this paper
• Intensity-modulated Radiotherapy in Patients With Aggressive Extranodal Non-Hodgkin Lymphoma of the Head and Neck

  2021cites this paper
• 'Le Roi est mort, vive le Roi': New Roles of Radiotherapy in the Treatment of Lymphomas in Combination With Immunotherapy.

  2021cites this paper
• Role of radiation therapy in primary tonsil large B cell lymphoma: a SEER-based analysis

  2021cites this paper
• Emerging Role of Consolidative Radiotherapy After Complete Remission Following R-CHOP Immunochemotherapy in Stage III–IV Diffuse Large B-Cell Lymphoma: A Single Institutional and Case-Matched Control Study

  2021influential citation
• Report from the Lymphoma Research Foundation Adolescent and Young Adult (AYA) Lymphoma Scientific Workshop, May 2019

  2020cites this paper
• Biomarkers and novel therapeutic approaches for diffuse large B-cell lymphoma in the era of precision medicine

  2020cites this paper
• Efficacy and safety of CD19 chimeric antigen receptor T cells in the treatment of 11 patients with relapsed/refractory B-cell lymphoma: a single-center study

  2020cites this paper
• Diffuse Large B-Cell Lymphomas in Older Adults

  2020cites this paper
• Treatment selection and survival outcomes in Early-Stage peripheral T-Cell lymphomas: does anaplastic lymphoma kinase mutation impact the benefit of consolidative radiotherapy?

  2020cites this paper
• CAR-T Cell Therapy for Lymphoma: How Does Radiation Therapy Fit In?

  2020cites this paper
• Association of progression-free or event-free survival with overall survival in diffuse large B-cell lymphoma after immunochemotherapy: a systematic review

  2020cites this paper
• Role of Radiation Therapy Differs Between Stages in Primary Bone Large B-Cell Lymphoma in Rituximab Era: A Population-Based Analysis

  2020cites this paper
• Involved Site Radiation Therapy in Adult Lymphomas: An Overview of International Lymphoma Radiation Oncology Group Guidelines.

  2020cites this paper
• Clinical Characteristics and Outcomes of Extranodal Stage I Diffuse Large B Cell Lymphoma in The Rituximab-Era.

  2020cites this paper
• CAR-T cell therapy for lymphoma: how does radiotherapy fit in?

  2020cites this paper
• Long-Term Results of PET-Guided Radiation in Advanced-Stage Diffuse Large B-Cell Lymphoma Patients Treated with R-CHOP.

  2020cites this paper
• Radiotherapy for Non-Hodgkin Lymphomas

  2020influential citation
• End-of-Treatment PET/Computed Tomography Response in Diffuse Large B-Cell Lymphoma.

  2019cites this paper
• Treatment of Non-Hodgkin Lymphoma Arising De Novo in Unilateral Tonsil

  2019cites this paper
• DIBH-VMAT for Consolidation RT in Mediastinal B-NHL can Significantly Reduce Doses to OAR Report of Two Cases

  2019cites this paper
• Radiotherapy Should Be Part of a Multidisciplinary Discussion for Most Patients With Lymphoma.

  2019cites this paper
• Phase 2 Study of Dose-Reduced Consolidation Radiation Therapy in Diffuse Large B-Cell Lymphoma.

  2019cites this paper
• Hitting a Moving Target: Successful Management of Diffuse Large B-cell Lymphoma Involving the Mesentery With Volumetric Image-guided Intensity Modulated Radiation Therapy.

  2019cites this paper
• A multi-institutional and case-matched control study on treatment outcomes of consolidative radiotherapy after a full course of R-CHOP compared with R-CHOP alone in Stage I–II diffuse large B-cell lymphoma (KROG 17-02)

  2019cites this paper
• Absolute Clinical Radiation Oncology Review

  2019cites this paper
• Difficult-to-treat Syndrome of Inappropriate Antidiuretic Hormone Secretion in a Patient with Secondary Central Nervous System Lymphoma

  2019cites this paper
• A phase III randomized controlled trial of radiation dose optimization in non‐Hodgkin lymphoma‐diffuse large B‐cell lymphoma (DOBL study): Study protocol and design

  2019influential citation
• A Multi-institutional Analysis of Diffuse Large B-cell Lymphoma (DLBCL) Treated with Consolidative Radiotherapy and the Impact of Cell-of-origin on Outcomes

  2019cites this paper
• Patient Survival With and Without Radiation Therapy for Early-Stage Diffuse Large B-Cell Lymphoma in the Era of PET and Rituximab

  2019cites this paper
• 20 Gy Versus 30 Gy: Will it Make a Difference?

  2019cites this paper
• Role of radiotherapy in diffuse large B‐cell lymphoma in advanced stages on complete response after administration of cyclophosphamide, doxorubicin, vincristine, prednisone, and rituximab

  2019cites this paper
• Retracted article: Adjuvant radiotherapy in patients with diffuse large B-cell lymphoma in advanced stage (III/IV) improves the outcome in the rituximab era

  2019cites this paper
• Stage I non-Hodgkin lymphoma: no plateau in disease-specific survival ?

  2019cites this paper
• Adjuvant radiotherapy and chemotherapy in early-stage diffuse large B cell lymphoma of head and neck with extranodal involvement

  2019cites this paper
• Clinicopathological analysis of sinonasal malignant lymphoma in an HTLV-1 endemic area in Japan -special focus on primary sinonasal diffuse large B-cell lymphoma-

  2019cites this paper
• Systemic immune response associated with radiation therapy in B‑cell non‑Hodgkin's lymphoma of Waldeyer's ring.

  2018cites this paper
• Colorectal Lymphoma: A Review

  2018cites this paper
• INFRADIAPHRAGMAL RADIOTHERAPY IN PATIENTS WITH LYMPHOMA: VOLUME DEFINITION AND SIDE EFFECTS

  2018cites this paper
• Successful role of radiation therapy: Account for every single gray and make every single gray count.

  2018cites this paper
• Case Report: Coexistence of Papillary Thyroid Cancer and Thyroid Lymphoma

  2018influential citation
• PET/CT for Lymphoma Post-therapy Response Assessment in Hodgkin Lymphoma and Diffuse Large B-cell Lymphoma.

  2018cites this paper
• Isolated Non Hodgkin Lymphoma of the Base of Tongue –A Case Report

  2018cites this paper
• FDG‐PET/CT in the management of lymphomas: current status and future directions

  2018cites this paper
• Non-Hodgkin’s Lymphoma

  2018cites this paper
• Role of consolidative radiation therapy for patients with mediastinal diffuse large B-cell lymphoma in the rituximab era

  2018cites this paper
• Radiation Therapy in Diffuse Large B-Cell Lymphoma

  2018cites this paper
• Lymphoma of Bone

  2018cites this paper
• R-CHOP 14 with or without radiotherapy in nonbulky limited-stage diffuse large B-cell lymphoma.

  2018cites this paper
• The contribution of discoidin domain receptor 1 to the pathogenesis of diffuse large B cell lymphoma

  2018cites this paper
• Volatile metabonomic profiling in urine to detect novel biomarkers for B-cell non-Hodgkin's lymphoma

  2018cites this paper
• Expression patterns of the activator protein-1 (AP-1) family members in lymphoid neoplasms

  2017cites this paper
• Long-term outcome of diffuse large B-cell lymphoma: Impact of biosimilar rituximab and radiation.

  2017cites this paper
• фома Ходжкина, лекарственная терапия. SUMMARY APPLICATION OF MODIFICATIONS OF PREVAILING DRUG TREATMENT REGIMENS IN PATIENTS WITH MALIGNANT LYMPHOMAS (PROGNOSIS AND QUALITY OF LIFE) V.P.Gordienko1, N.A.Tovbik2, D.S.Rudenko2

  2017cites this paper
• Oncologists’ Perspectives on Consolidation Radiation Treatment after Chemotherapy for Lymphomas: A Survey Study by the Lymphoma Working Committee of the Turkish Oncology Group (TOG)

  2017cites this paper